Advertisement
Screener

Co-Diagnostics, Inc. (CODX) Interest Expense, Other

2.8 / 5 stars · 68/120 Roast Me

Co-Diagnostics, Inc. Interest Expense, Other

Co-Diagnostics, Inc. (CODX) reported Interest Expense, Other of $106.44 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpenseOther · last filed 2020-11-16

  • Co-Diagnostics, Inc. interest expense, other for the quarter ending 2019-12-31 was $0.00, a 100.00% decline year-over-year.
  • Co-Diagnostics, Inc. interest expense, other for the quarter ending 2019-09-30 was $10.00, a 99.98% decline year-over-year.
  • Co-Diagnostics, Inc. interest expense, other for the quarter ending 2019-06-30 was $0.00.
  • Co-Diagnostics, Inc. interest expense, other for the quarter ending 2019-03-31 was $106.43K.
  • Co-Diagnostics, Inc. interest expense, other for fiscal 2019 was $106.44K, a 21.13% decline from fiscal 2018.
  • Co-Diagnostics, Inc. interest expense, other for fiscal 2018 was $134.95K, a 56.50% decline from fiscal 2017.
  • Co-Diagnostics, Inc. interest expense, other for fiscal 2017 was $310.23K.
Period endInterest Expense, Other 3 monthInterest Expense, Other 6 monthInterest Expense, Other 9 monthInterest Expense, Other 12 month
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$10.00
derived: sum of 2 quarters · filed 2020-11-16
$10.00
derived: sum of 3 quarters · filed 2020-11-16
$106.44K
10-K · filed 2020-03-30
2019-09-30$10.00
10-Q · filed 2020-11-16
$10.00
derived: sum of 2 quarters · filed 2020-11-16
$106.44K
10-Q · filed 2020-11-16
$192.53K
derived: sum of 4 quarters · filed 2020-11-16
2019-06-30$0.00
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03
$106.43K
10-Q/A · filed 2020-11-03
$192.52K
derived: sum of 3 quarters · filed 2020-11-03
$241.37K
derived: sum of 4 quarters · filed 2020-11-03
2019-03-31$106.43K
10-Q · filed 2020-05-14
$192.52K
derived: sum of 2 quarters · filed 2020-05-14
$241.37K
derived: sum of 3 quarters · filed 2020-05-14
2018-12-31$86.09K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
$134.95K
derived: sum of 2 quarters · filed 2020-03-30
$134.95K
10-K · filed 2020-03-30
2018-09-30$48.86K
10-Q · filed 2019-11-12
$48.86K
10-Q · filed 2019-11-12
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
$14.80K
derived: sum of 2 quarters · filed 2019-04-01
$168.86K
derived: sum of 3 quarters · filed 2019-04-01
$310.23K
10-K · filed 2019-04-01
2017-09-30$14.80K
10-Q · filed 2018-11-14
$168.86K
derived: sum of 2 quarters · filed 2018-11-14
$310.23K
10-Q · filed 2018-11-14
2017-06-30$154.06K
10-Q · filed 2018-08-10
$295.43K
10-Q · filed 2018-08-10
2017-03-31$141.38K
10-Q · filed 2018-05-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
enVVeno Medical Corp (NVNO)United States$0.006B-0.48
Sonoma Pharmaceuticals, Inc. (SNOA)United States$0.006B-2.59
INTELLIGENT BIO SOLUTIONS INC. (INBS)United States$0.005B
AETHLON MEDICAL INC (AEMD)United States$0.005B
Bluejay Diagnostics, Inc. (BJDX)United States$0.004B
OSR Health, Inc. (OSRH)United States$0.004B-0.75
Adagio Medical Holdings, Inc. (ADGM)United States$0.004B
ALLURION TECHNOLOGIES, INC. (ALUR)United States$0.010B
Autonomix Medical, Inc. (AMIX)United States$0.004B
Picard Medical, Inc. (PMI)United States$0.011B-0.01